Search results
Results from the WOW.Com Content Network
NCI has also been cited as a "Resource on Autism" by NBC News. [11] NCI indicators contribute to the calculation of state rankings in United Cerebral Palsy's report The Case for Inclusion. [12] Data from the National Core Indicators surveys also provide a rich source of data on demographics, personal characteristics, work status, and services ...
The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI) is a source of epidemiologic information on the incidence and survival rates of cancer in the United States.
1955: NCI established the Clinical Trials Cooperative Group Program, which included several research networks that conducted cancer clinical research primarily under the sponsorship of NCI. 1957: The first cancer, choriocarcinoma, was cured with chemotherapy at NCI. 1960: NCI began funding government-supported cancer centers.
NCI Reports Fourth Quarter and Fiscal Year 2012 Financial and Operating Results Diluted fourth quarter earnings per share (EPS) $0.15, excluding charge; full-year EPS $0.51, excluding charges
[18] [17] [15] As of 2023, MD Anderson Cancer Center is home to the highest number of cancer clinical trials in the world and has received more NCI-funded projects than any other U.S. institute. [19] [3] For 2024, Newsweek placed MD Anderson at #1 in their annual list of the World's Best Specialized Hospitals in oncology. [20]
In 2021, NCI undertook a pilot project to oversample cancer survivors using three cancer registries from the Surveillance, Epidemiology, and End Results (SEER) Program (https://seer.cancer.gov) as a sampling frame of cancer survivors. The pilot project, called HINTS-SEER, was designed to provide a larger sample of cancer survivors for analyses.
The NCI named Siteman a Comprehensive Cancer Center in 2005, recognizing its broad-based research, outreach and education activities, and awarded the center a five-year, $21 million support grant. [13] The NCI renewed the designation in 2010 and awarded another five-year grant, totaling $23 million.
The NCI-60 cancer cell line panel is a group of 60 human cancer cell lines used by the National Cancer Institute (NCI) for the screening of compounds to detect potential anticancer activity. [ 1 ] Purpose